scientist-labcoat-dna
30 April 2013AmericasJames Monroe and Lawrence Ilag

Obviousness of DNA fragments in the post-Kubin era

Four years ago, the Federal Circuit held in In re Kubin, 561 F.3d 1351 (Fed. Cir. 2009) that the claimed polynucleotide (DNA) sequences in that case were obvious, although the prior art did not disclose or suggest what the claimed sequences would look like. In effect, the Federal Circuit found the sequences obvious because the prior art disclosed sufficient information to make isolating and characterising the claimed DNA sequences a rather straightforward project.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
25 February 2026   The Danish company is contending with fierce competition, a clinical trial setback and a UK boost to its main rival, while making new moves to enforce its weight-loss-drug IP.
Americas
20 February 2026   The German biotech claims the newly approved vaccine infringes its mRNA patent, deepening an already complex feud with billions of dollars at stake.
Americas
19 February 2026   An EPO appeals board has denied Boston Scientific’s bid to revoke St Jude Medical’s transcatheter aortic valve replacement (TAVR) patent, but declined to hand a complete victory to the patent owner.